Dental Implants Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Dental Implants (Premium, Value, Discount, Mini), Final Abutments (Stock, Custom Cast, CAD/CAM), and 3 more
According to market research, the U.S. market for dental implants and final abutments was worth $1.4 billion in 2022. It is expected that this market will grow steadily at a compound annual growth rate (CAGR) of 6.4% during the forecast period, reaching an estimated value of $2.2 billion by 2029.
This comprehensive report covers all aspects of the U.S. market for dental implants and final abutments, including dental implants, final abutments, instrument kits, treatment planning software, and surgical guides.
DATA TYPES INCLUDED IN THIS REPORT
Unit Sales, Average Selling Prices, Market Value & Growth Trends
Market Forecasts Until 2029 & Historical Data to 2019
Competitive Analysis with Market Shares for Each Market Segment
Market Drivers & Limiters
Recent Mergers & Acquisitions
COVID19 Impact on the DI Market in the US
Disease Overviews & Demographic Information
Company Profiles, Product Portfolios & SWOT for Top Competitor
U.S. DENTAL IMPLANT MARKET TRENDS
There are several factors that will contribute to the growth of the dental implant and final abutment market in the U.S. These factors include the consolidation of individual dental clinics into group practices and dental service organizations (DSOs), the cost efficiency of dental implant procedures over the long term, ongoing technological advancements in dental implant procedures, and a relatively low penetration rate of dental implants among the U.S. population.
Moreover, the increasing demand for aesthetics and the rising number of general practitioners who are now placing dental implants are also expected to drive the growth of this market. With all-time highs in the efficacy of dental implant procedures, the market is projected to grow in the high-single-digit range between 2022 and 2029.
U.S. DENTAL IMPLANT MARKET SHARE INSIGHTS
Out of 40+ dental implant companies analyzed, the majority of the U.S. market share was controlled by Straumann Group, Envista, and Dentsply Sirona.
In 2022, Straumann Group emerged as the leading competitor in the dental implant and final abutment market. The company has a strong advantage due to its well-established brand name recognition and its reputation for developing high-quality dental implants. Historically, Straumann has dominated the premium implant segment, thanks to its suite of dental implant-associated products that have proven successful across a wide range of applications.
Additionally, Straumann's subsidiary, Neodent, has performed exceptionally well in the value implant segment, further cementing Straumann's position as a clear leader in the dental implant market. With its proven track record of success and strong market position, Straumann is poised to continue leading the way in the dental implant industry.
MARKET SEGMENTATION SUMMARY
U.S. Market Segment for Dental Implants – Includes:
Premium, value, discount, and mini-implant products.
U.S. Market Segment for Final Abutments – Includes:
Stock, custom cast, and CAD/CAM abutments.
U.S. Market Segment for Dental Implant Instrument Kits – Includes:
Instrument kits and potential market for instrument kits.
U.S. Market Segment for Treatment Planning Software – Includes:
Treatment planning software, and treatment planning software maintenance fee
U.S. Market Segment for Surgical Guides – Includes:
Traditional surgical guides, third-party surgical guides, and in-house surgical guides.
RESEARCH SCOPE SUMMARY
Regions: North America (United States)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook